The NGLY1 gene gives cells instructions for an enzyme that removes sugar tags from damaged proteins so the cell can break them down and recycle them. This gene plays an important role in the cell’s protein cleanup system. If both copies of the NGLY1 gene do not work, a person can develop NGLY1 deficiency, a rare inherited condition linked to developmental delay, movement differences, low or absent tears, seizures, and sometimes liver problems.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or manage processes in the body. Some genes carry the information needed to make proteins, the functional parts of cells. Other genes mainly help regulate when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. To explore this topic in more detail, you can find more in the LearnHub.
Overview
NGLY1Gene function
What if the gene works
The NGLY1 gene helps cells remove sugar tags from certain damaged proteins so they can be broken down and recycled. This supports protein quality control and helps cells keep their protein disposal system working properly.
Risk
What if the gene does not work
More disruptive variants in the NGLY1 gene can cause NGLY1 deficiency, a rare condition that often affects development and movement and may reduce tear production. Milder variants may lead to earlier or later symptoms and a wider range of severity.
Treatment
What does that mean for your treatment
For pathogenic or loss-of-function variants in the NGLY1 gene, no gene-specific treatment or drug selection approach is currently established. Care is based on symptoms, and research is exploring replacement therapies and other targeted approaches, but these remain experimental.
Conditions associated with NGLY1
Gene function
What if the gene works
Your cells are constantly making, checking, and clearing proteins. The NGLY1 gene supports this everyday quality control by removing sugar chains from certain proteins at the right time. It also helps cells adjust their protein recycling system, so the NGLY1 gene function is closely tied to smooth protein cleanup and reuse.
NGLY1 removes sugar chains from proteins that did not fold properly. This helps prepare those proteins for breakdown after they are moved out of the cell's protein-folding area.
Its protein helps activate NFE2L1, a control protein that tells cells to make proteasomes (protein recycling units). This lets cells match their cleanup capacity to everyday demand.
By linking protein checking, sugar removal, and disposal, NGLY1 supports steady protein turnover. This helps cells keep routine internal housekeeping organized.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental influences. Many do not produce any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more strongly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NGLY1 gene can alter the enzyme’s shape, stability, or working part, so it is broken down faster or loses much of its sugar-removing activity. This is how NGLY1 gene variants affect protein function: milder missense variants may leave some residual activity, while more disruptive nonsense, frameshift, or splice variants often leave little or no working protein, which can influence cellular effects and how early and how strongly features of NGLY1 deficiency appear.
How variants are linked to conditions
The clearest example of how NGLY1 gene variants are linked to conditions is NGLY1 deficiency, a rare inherited condition caused by pathogenic variants in both copies of the NGLY1 gene. People with this diagnosis often have developmental delay, movement differences, low or absent tears, and may also have liver problems or seizures. This is a confirmed genetic condition, not just a risk pattern.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely seen across the general population. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant connected with a condition indicates a possible association, not a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one specific well-studied variant in a given gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NGLY1, risk is mostly set by inheritance rather than lifestyle. A child is affected when they inherit a changed NGLY1 gene from both parents, so family history and whether both parents carry a variant are the main factors that change risk. There is not enough evidence to say that diet, exercise, or other everyday habits lower this genetic risk.
Inheritance of NGLY1 variants
NGLY1-related disease follows an autosomal recessive inheritance pattern. This means a child inherits one altered copy of the NGLY1 gene from each parent, and the parents are usually healthy carriers. When both parents carry a variant in the NGLY1 gene, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two working copies. In families asking how NGLY1 variants are inherited, this is the well-established pattern seen for NGLY1 deficiency.
What does my NGLY1 result mean for my family?
NGLY1-related disease is usually passed down in a recessive way, which means parents are often healthy carriers. For family members, this can mean brothers and sisters may also be affected or may be carriers, and other relatives may carry the same gene change without knowing it. Future children in the family may also be at risk if both parents carry an NGLY1 change.
Genetic information
Genetic testing
How you find out about variants
NGLY1 genetic testing usually uses a blood or saliva sample to read the NGLY1 gene and look for variants linked to NGLY1 deficiency. It may be done as single-gene testing, on a broader panel, or through exome sequencing, which reads many genes at once.
When should I consider getting a genetic test?
Testing for changes in the NGLY1 gene may be considered when a child has a pattern of problems linked to this gene, such as developmental delay, unusual movements, seizures, liver problems, or very few tears. It can also help if there is a known NGLY1 change in the family or an affected brother or sister.
A genetic result is only one part of your health story
A genetic result can provide useful insight, yet how much it reveals depends on the condition and on the type of variant involved. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines and how strongly you respond to them. These inherited differences are common and can help explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people. Medication response also depends on other factors, including age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medications. It focuses on gene and drug patterns to help explain why the same treatment can work differently in different people. With many medicines, genes can influence how much effect a drug has or how the body handles it. This information can support more informed, more personalized treatment decisions. To look into this subject more closely, you can learn more in the LearnHub.
Drugs influenced by the NGLY1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or your health are best discussed with your doctor. Early research on the NGLY1 gene has looked at how cells respond to some cancer treatments that affect protein breakdown, but this has not become part of routine care.
History
Interest in the NGLY1 gene grew after doctors linked it to a newly recognized rare inherited condition in the early 2010s. In 2012, families, clinicians, and researchers helped bring together scattered cases that had looked unrelated at first. The first detailed reports soon followed, and the condition became known as NGLY1 deficiency, the first disorder described in a group later called congenital disorders of deglycosylation. From these first observations, research expanded steadily. Patient advocacy played an unusually visible role, with families helping drive awareness, fundraising, and international collaboration. That early partnership between families and scientists made the NGLY1 gene an important example of how rare disease discoveries can move forward.